## Abstract Patients with idiopathic Parkinson's disease suffer not only from classic motor symptoms, but from deficits in cognitive function, primarily those subserved by the prefrontal cortex as well. The aim of the current study was to investigate the modulatory effects of dopaminergic therapy o
β¦ LIBER β¦
Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease
β Scribed by Roshan Cools
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 385 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0149-7634
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dopaminergic modulation of cortical func
β
Venkata S. Mattay; Alessandro Tessitore; Joseph H. Callicott; Alessandro Bertoli
π
Article
π
2002
π
John Wiley and Sons
π
English
β 399 KB
π 2 views
Effects of dopaminergic treatment on bla
β
Kristian Winge; Lene M. Werdelin; Kurt K. Nielsen; Hans Stimpel
π
Article
π
2004
π
John Wiley and Sons
π
English
β 155 KB
Comparative study of selegiline plus L-d
β
Timothy Brannan; Dr. Melvin D. Yahr
π
Article
π
1995
π
John Wiley and Sons
π
English
β 383 KB
π 1 views
The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o
Potential mechanisms underlying anxiety
β
Karen L. Eskow Jaunarajs; Mariana Angoa-Perez; Donald M. Kuhn; Christopher Bisho
π
Article
π
2011
π
Elsevier Science
π
English
β 449 KB
Role of iron and iron chelation in dopam
β
Dr. D. Ben-Shachar; G. Eshel; P. Riederer; M. B. H. Youdim
π
Article
π
1992
π
John Wiley and Sons
π
English
β 531 KB
Evidence for long-term survival and func
β
Dr. Olle Lindvall; Guy Sawle; HΓ₯kan Widner; John C. Rothwell; Anders BjΓΆrklund;
π
Article
π
1994
π
John Wiley and Sons
π
English
β 899 KB